The doctor-patient relationship in the generative AI era
Five reasons why the time to act for pharma is now.
Generative AI is revolutionising the medical advice landscape, redefining the doctor-patient dynamic in ways previously unimaginable. This brings both huge opportunities and formidable challenges…
Drawing on new research among healthcare professionals, along with our vast experience in this field, we explore these potential impacts in detail.
We also consider the implications for pharmaceutical companies, providing five key reasons why the time for action is now.
We conclude with an incontestable truth: this is a high-risk, high-reward field and the companies that take the lead stand to reap the most significant benefits.
